Scienture Holdings, Inc.
Datakwaliteit: 100%
SCNX
NASDAQ
Manufacturing
Chemicals
€ 0,35
▲
€ 0,01
(1,75%)
Marktkapitalisatie: 14,21 M
6 months return
—
Momentum
Neutral
5Y revenue growth
-54,29%
Quick Summary
Key Takeaways
Short bullets derived from reported financials—not the AI summary above.
Revenue declined -54,29% annually over 5 years
Earnings declined -557,90% over the past year
Debt/Equity of 0,02 — conservative balance sheet
Negative free cash flow of -13,39 M
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 270,16%
Capital efficient — spends only 2,78% of revenue on capex
Price History
Groei
Revenue Growth (5Y)
-54,29%
Onder sectorgemiddelde (1,82%)
Revenue (1Y)215,87%
Earnings (1Y)-557,90%
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-51,72%
Boven sectorgemiddelde (-54,49%)
ROIC-34,67%
Net Margin-9618,03%
Op. Margin-9867,92%
Veiligheid
Debt / Equity
0,02
Onder sectorgemiddelde (0,30)
Current Ratio0,19
Interest Coverage-10,43
Waardering
PE (TTM|NTM)
-0,34 | -1,59
Boven sectorgemiddelde (-1,50)
P/B Ratio0,17
EV/EBITDAN/A
Dividend YieldN/A
Financiële Trends
Sectorvergelijking
vs Manufacturing sector mediaan (1605 peers)
Vergeleken met vergelijkbare bedrijven in Manufacturing
Sectorvergelijking
vs Manufacturing sector mediaan (1605 peers) Vergeleken met vergelijkbare bedrijven in Manufacturing| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -0,3 | -1,5 |
| P/B | 0,2 | 1,6 |
| ROE % | -51,7 | -54,5 |
| Net Margin % | -9618,0 | -41,5 |
| Rev Growth 5Y % | -54,3 | 1,8 |
| D/E | 0,0 | 0,3 |
Koersdoel Analisten
1 analist
Consensus van analisten: gemiddeld koersdoel vs huidige prijs en beoordeling.
Strong Buy
Huidig
€ 0,35
Koersdoel
€ 1,50
€ 1,50
€ 1,50
€ 1,50
Vooruitzicht
Forward K/W
-1,59
Forward WPA
-€ 0,21
Omzet Sch.
17,22 M
Winstschattingen
Analistprognoses voor EPS en omzet per periode. Jaar = boekjaren; kwartaal = komende kwartalen.
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2027 |
-€ 0,21
-€ 0,21 – -€ 0,21
|
17,22 M | 1 |
| FY2026 |
-€ 0,72
-€ 0,72 – -€ 0,72
|
5,07 M | 1 |
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| 2026 Q2 |
-€ 0,23
-€ 0,23 – -€ 0,23
|
0,0 | 1 |
| 2026 Q1 |
-€ 0,22
-€ 0,22 – -€ 0,22
|
0,0 | 1 |
Winstverassingen
Laatste 1 kwartaal
| Kwartaal | Geschat WPA | Werkelijk WPA | Verrassing |
|---|---|---|---|
| Q42025 | -€ 0,28 | -€ 0,13 | +54,7% |
Dividendgeschiedenis
Recente betalingen per aandeel (nieuwste eerst).
| Ex-dividend | Betaling | Bedrag / aandeel |
|---|---|---|
| Jul 19, 2024 | — | € 1,50 |
| Mar 25, 2024 | — | € 8,00 |
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 215,87% | Revenue Growth (3Y) | -77,16% |
| Earnings Growth (1Y) | -557,90% | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | -54,29% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 431.609,0 | Net Income (TTM) | -41,51 M |
| ROE | -51,72% | ROA | -39,70% |
| Gross Margin | 76,80% | Operating Margin | -9867,92% |
| Net Margin | -9618,03% | Free Cash Flow (TTM) | -13,39 M |
| ROIC | -34,67% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,02 | Current Ratio | 0,19 |
| Interest Coverage | -10,43 | Asset Turnover | 0,00 |
| Working Capital | -5,93 M | Tangible Book Value | -15,10 M |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | 1 yrs | ||
| Valuation | |||
| P/E Ratio | -0,34 | Forward P/E | -1,59 |
| P/B Ratio | 0,17 | P/S Ratio | 32,92 |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | 0,83 | Fwd Earnings Yield | N/A |
| FCF Yield | -94,25% | ||
| Market Cap | 14,21 M | Enterprise Value | 16,21 M |
| Per Share | |||
| EPS (Diluted TTM) | -2,70 | Revenue / Share | 0,01 |
| FCF / Share | -0,33 | OCF / Share | -0,33 |
| EPS CAGR (1Y) | -208,87% | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | 2,78% | FCF Conversion | 32,26% |
| SBC-Adj. FCF | -15,21 M | Growth Momentum | 270,16 |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2023 | FY2024 | FY2022 | FY2020 |
|---|---|---|---|---|---|
| Revenue | 431.609,0 | 8,27 M | 136.643,0 | 11,45 M | 17,12 M |
| Net Income | -41,51 M | -17,84 M | 9,07 M | -3,47 M | -2,54 M |
| EPS (Diluted) | -2,70 | -7,49 | 2,48 | -0,41 | — |
| Gross Profit | 331.482,0 | 2,60 M | 6.005,0 | 5,45 M | 5,71 M |
| Operating Income | -42,59 M | -7,26 M | -14,70 M | -4,42 M | -2,51 M |
| EBITDA | — | — | — | — | — |
| R&D Expenses | 1,96 M | — | 2,24 M | — | — |
| SG&A Expenses | — | — | — | — | — |
| D&A | 491.781,0 | — | — | — | — |
| Interest Expense | 4,08 M | 1,20 M | 1,34 M | 336.206,0 | 29.389,0 |
| Income Tax | -1,99 M | — | -534.396,0 | — | — |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2023 | FY2024 | FY2022 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 84,18 M | 12,53 M | 104,85 M | 3,71 M | 9,79 M |
| Total Liabilities | 14,06 M | 11,99 M | 25,78 M | 3,37 M | 1,11 M |
| Shareholders' Equity | 70,12 M | 542.353,0 | 79,07 M | 763.136,0 | 8,68 M |
| Total Debt | 2,90 M | — | 2,90 M | — | — |
| Cash & Equivalents | 6,66 M | 151.908,0 | — | 1,13 M | 5,92 M |
| Current Assets | 7,92 M | 2,75 M | 6,31 M | 2,09 M | 9,22 M |
| Current Liabilities | 2,74 M | 11,56 M | 7,91 M | 2,15 M | 842.238,0 |
{"event":"ticker_viewed","properties":{"ticker":"SCNX","listing_kind":"stock","pathname":"/stocks/scnx","exchange":"NASDAQ","country":"US"}}